Overview

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
0
Participant gender:
All
Summary
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
UCB Pharma
Treatments:
Cetirizine
Levocetirizine
Criteria
Inclusion Criteria:

- male or female ≥ 12 years

- suffering from a perennial allergic rhinitis to house dust mites for at least 2 years

- positive skin test or positive Radio-Allergo-Sorbent-Test for house dust mites

- the mean of the T4SS evaluated in the evening over the last 24 hours of the selection
period was ≥ 5

Exclusion Criteria:

- seasonal allergic rhinitis likely to change significantly the symptoms of the subject

- an ear, nose or throat (ENT) infection during the two weeks preceding initial visit

- asthma requiring corticosteroid treatment

- atopic dermatitis or urticaria requiring an antihistamine treatment or the
administration of oral or topical corticosteroids

- associated ENT disease